EU rules on animal tissue devices due this year
This article was originally published in Clinica
The European Commission Decision on medical devices containing animal tissues, a ruling that sets out what are effectively mandatory requirements for these controversial products, could be adopted by November. And even if there are setbacks in the anticipated approval schedule, the Commission is optimistic that the text will now be adopted by the end of the year.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.